Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-14 BOLL ANDREW R. PRESIDENT AND CFO Purchase +3,500 $29.90 $105K 814,679
2025-12-12 BOLL ANDREW R. PRESIDENT AND CFO Exercise or conversion +60,000 $3.95 $237K 837,844
2025-12-12 BOLL ANDREW R. PRESIDENT AND CFO Shares withheld for taxes −26,665 $47.06 $1.3M 811,179
2025-12-12 BOLL ANDREW R. PRESIDENT AND CFO Exercise or conversion · Stock Option (Right to Buy) −60,000 0
2025-07-01 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Grant or award · RSU +405,750 405,750
2025-04-07 BOLL ANDREW R. Chief Financial Officer Shares withheld for taxes −136,745 $23.09 $3.2M 777,844
2025-04-03 BOLL ANDREW R. Chief Financial Officer Exercise or conversion +346,500 914,589
2025-04-03 BOLL ANDREW R. Chief Financial Officer Exercise or conversion · Performance Stock Unit −346,500 0
2024-02-20 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Exercise or conversion +45,000 $10.67 $480K 586,569
2024-02-20 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Exercise or conversion −18,480 $10.67 $197K 568,089
2024-02-20 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Exercise or conversion · RSU −45,000 0
2024-02-07 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Exercise or conversion +7,400 $7.71 $57K 541,569
2024-02-07 BOLL ANDREW R. CHIEF FINANCIAL OFFICER Exercise or conversion · Stock Option (Right to Buy) −7,400 0
2023-07-18 BOLL ANDREW R. Chief Financial Officer Exercise or conversion +346,500 670,519
2023-07-18 BOLL ANDREW R. Chief Financial Officer Shares withheld for taxes −136,350 $18.23 $2.5M 534,169
2023-07-18 BOLL ANDREW R. Chief Financial Officer Exercise or conversion · Performance Stock Unit −346,500 0
2023-04-03 BOLL ANDREW R. Chief Financial Officer Grant or award · Restricted Stock Unit +346,500 346,500
2023-03-31 BOLL ANDREW R. Chief Financial Officer Exercise or conversion +90,000 $6.00 $540K 358,461
2023-03-31 BOLL ANDREW R. Chief Financial Officer Shares withheld for taxes −34,442 $21.16 $729K 324,019
2023-03-31 BOLL ANDREW R. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −90,000 0

Page 1 of 3 · 56 trades